The invention relates to new derivatives of 2-(iminomethyl)amino-phenyl
which are NO synthase inhibitors and can trap reactive oxygen species.
These compounds can notably be used for the treatment of stroke, of
neurodegenerative diseases and of ischemic or hemorragic cardiac or
cerebral infarctions.
These compounds include:
N-{4-[({[4-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl}ami-
no)methyl]phenyl}thiophene-2-carboximidamide;
N-{3-[({[4-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl}ami-
no)methyl]phenyl}thiophene-2-carboximidamide;
N-(4-{[{[4-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl}(me-
thyl)amino]methyl}phenyl)thiophene-2-carboximidamide;
N-[3-({[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]amino}methyl)phenyl]th-
iophene-2-carboximidamide;
N-(3-{[(3,5-di-tert-butyl-4-hydroxybenzyl)amino]methyl}phenyl)thiophene-2--
carboximidamide;
N-[3-({[2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethyl]amino}methyl)phenyl]thi-
ophene-2-carboximidamide;
N-[3-({[3-(4-hydroxy-3,5-diisopropylphenyl)propyl]amino}methyl)phenyl]thio-
phene-2-carboximidamide;
N-(3-{[(4-hydroxy-3,5-diisopropylbenzyl)amino]methyl}phenyl)thiophene-2-ca-
rboximidamide;
N-[3-({[2-(4-hydroxy-3,5-diisopropylphenyl)ethyl]amino}methyl)phenyl]thiop-
hene-2-carboximidamide;
N-2-(3,5-di-tert-butyl-4-hydroxybenzoyl)-N-1-(4-{[imino(thien-2-yl)methyl]-
amino}phenyl)-L-leucinamide;
and pharmaceutically acceptable salts thereof.
